Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 2
2010 4
2012 2
2013 1
2014 1
2015 1
2017 1
2018 1
2019 1
2020 2
2021 2
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Right Heart Failure in Pulmonary Hypertension.
Cassady SJ, Ramani GV. Cassady SJ, et al. Among authors: ramani gv. Cardiol Clin. 2020 May;38(2):243-255. doi: 10.1016/j.ccl.2020.02.001. Cardiol Clin. 2020. PMID: 32284101 Review.
Right heart failure is a major cause of morbidity and mortality in pulmonary hypertension. Its pathophysiology is complex and involves both adaptive and maladaptive patterns of right ventricular change. ...
Right heart failure is a major cause of morbidity and mortality in pulmonary hypertension. Its pathophysiology is complex and …
BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension.
Spikes LA, Bajwa AA, Burger CD, Desai SV, Eggert MS, El-Kersh KA, Fisher MR, Johri S, Joly JM, Mehta J, Palevsky HI, Ramani GV, Restrepo-Jaramillo R, Sahay S, Shah TG, Deng C, Miceli M, Smith P, Shapiro SM. Spikes LA, et al. Among authors: ramani gv. Pulm Circ. 2022 Apr 7;12(2):e12063. doi: 10.1002/pul2.12063. eCollection 2022 Apr. Pulm Circ. 2022. PMID: 35514770 Free PMC article.
Inhaled treprostinil is an approved therapy for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease in the United States. ...
Inhaled treprostinil is an approved therapy for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated wi …
Effects of ranolazine on right ventricular function, fluid dynamics, and metabolism in patients with precapillary pulmonary hypertension: insights from a longitudinal, randomized, double-blinded, placebo controlled, multicenter study.
Han QJ, Forfia P, Vaidya A, Ramani G, deKemp RA, Mach RH, Mankoff DA, Bravo PE, DiCarli M, Chan SY, Waxman AB, Han Y. Han QJ, et al. Among authors: ramani g. Front Cardiovasc Med. 2023 Jun 13;10:1118796. doi: 10.3389/fcvm.2023.1118796. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37383703 Free PMC article.
INTRODUCTION: Right ventricular (RV) function is a major determinant of outcome in patients with precapillary pulmonary hypertension (PH). We studied the effect of ranolazine on RV function over 6 months using multi-modality imaging and biochemical markers in patien …
INTRODUCTION: Right ventricular (RV) function is a major determinant of outcome in patients with precapillary pulmonary hypertensi …
Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension.
Ramani GV, Park MH. Ramani GV, et al. Drug Des Devel Ther. 2010 May 25;4:61-70. doi: 10.2147/dddt.s6208. Drug Des Devel Ther. 2010. PMID: 20531962 Free PMC article. Review.
Sildenafil is approved only for treatment of PAH, and although emerging data suggest a potential role in treating other types of pulmonary hypertension, larger trials are required to confirm these findings....
Sildenafil is approved only for treatment of PAH, and although emerging data suggest a potential role in treating other types of pulmonar …
Pulmonary thromboendarterectomy in hospitalized versus elective patients with chronic thromboembolic pulmonary hypertension.
Awad MA, Cires-Drouet R, Ramani G, Leibowitz JL, Shah A, Lau CL, Griffith BP. Awad MA, et al. Among authors: ramani g. J Thorac Cardiovasc Surg. 2024 Feb;167(2):526-534. doi: 10.1016/j.jtcvs.2023.08.018. Epub 2023 Aug 22. J Thorac Cardiovasc Surg. 2024. PMID: 37611847
Patients in the hospitalized group were less likely to have chronic lung disease, history of pulmonary embolism and hypertension, be on anticoagulation and medication for pulmonary hypertension, and present with >1 month of respiratory symptoms. ...
Patients in the hospitalized group were less likely to have chronic lung disease, history of pulmonary embolism and hypertension, be on anti …
Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry.
DuBrock HM, Burger CD, Bartolome SD, Feldman JP, Ivy DD, Rosenzweig EB, Sager JS, Presberg KW, Mathai SC, Lammi MR, Klinger JR, Eggert M, De Marco T, Elwing JM, Badesch D, Bull TM, Cadaret LM, Ramani G, Thenappan T, Ford HJ, Al-Naamani N, Simon MA, Mazimba S, Runo JR, Chakinala M, Horn EM, Ryan JJ, Frantz RP, Krowka MJ. DuBrock HM, et al. Among authors: ramani g. Pulm Circ. 2021 May 17;11(3):20458940211020913. doi: 10.1177/20458940211020913. eCollection 2021 Jul-Sep. Pulm Circ. 2021. PMID: 34158918 Free PMC article.
We performed a cross-sectional study of adults enrolled in the Pulmonary Hypertension Association Registry. Patients with IPAH (n = 344) and POPH (n = 57) were compared. ...
We performed a cross-sectional study of adults enrolled in the Pulmonary Hypertension Association Registry. Patients with IPAH …
Identification of novel genetic variants, including PIM1 and LINC01491, with ICD-10 based diagnosis of pulmonary arterial hypertension in the UK Biobank cohort.
Pu A, Ramani G, Chen YJ, Perry JA, Hong CC. Pu A, et al. Among authors: ramani g. Front Drug Discov (Lausanne). 2023;3:1127736. doi: 10.3389/fddsv.2023.1127736. Epub 2023 Feb 8. Front Drug Discov (Lausanne). 2023. PMID: 37089865 Free PMC article.
Here, we conducted a genome-wide association study (GWAS) using the UK Biobank, analyzing the genomes of 493 individuals diagnosed with primary pulmonary hypertension, based on ICD-10 coding, compared to 24,650 age, sex, and ancestry-matched controls in a 1:50 case- …
Here, we conducted a genome-wide association study (GWAS) using the UK Biobank, analyzing the genomes of 493 individuals diagnosed with prim …
Rationale and design of the ranolazine PH-RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension.
Han Y, Forfia PR, Vaidya A, Mazurek JA, Park MH, Ramani G, Chan SY, Waxman AB. Han Y, et al. Among authors: ramani g. Open Heart. 2018 Feb 23;5(1):e000736. doi: 10.1136/openhrt-2017-000736. eCollection 2018. Open Heart. 2018. PMID: 29531764 Free PMC article.
We aim to study the effect of ranolazine on RV function using cardiovascular magnetic resonance (CMR) in patients with pulmonary hypertension (non-group 2 patients) and monitor the effect of ranolazine on metabolism using metabolic profiling and changes of microRNA. …
We aim to study the effect of ranolazine on RV function using cardiovascular magnetic resonance (CMR) in patients with pulmonary h …
23 results